Dynavax Technologies Corporation (DVAX)

NASDAQ: DVAX · Real-Time Price · USD

10.83

+0.24 (2.32%)

At close: Aug 13, 2025, 4:00 PM

10.75

-0.07 (-0.65%)

Pre-market: Aug 14, 2025, 9:05 AM EDT

Dynavax Technologies Market Cap

Dynavax Technologies has a market cap or net worth of $1.27 billion as of August 14, 2025. Its market cap has decreased by -16.18% in one year.

Market Cap

1.27B

Enterprise Value

944.67M

1-Year Change

-16.18%

Ranking

#2329

Market Cap Chart

Since February 19, 2004, Dynavax Technologies's market cap has increased from $222.50M to $1.27B, an increase of 470.53%. That is a compound annual growth rate of 8.44%.

Market Cap History

Date	Market Cap	% Change
Aug 13, 2025	1.27B	-24.42%
Dec 31, 2024	1.68B	-7.11%
Dec 29, 2023	1.81B	33.12%
Dec 30, 2022	1.36B	-19.57%
Dec 31, 2021	1.69B	244.22%
Dec 31, 2020	490.30M	2.21%
Dec 31, 2019	479.70M	-16.37%
Dec 31, 2018	573.60M	-49.38%
Dec 29, 2017	1.13B	644.48%
Dec 30, 2016	152.20M	-83.61%
Dec 31, 2015	928.40M	109.43%
Dec 31, 2014	443.30M	-13.87%
Dec 31, 2013	514.70M	1.06%
Dec 31, 2012	509.30M	20.97%
Dec 30, 2011	421.00M	13.85%
Dec 31, 2010	369.80M	531.06%
Dec 31, 2009	58.60M	74.93%
Dec 31, 2008	33.50M	-83.51%
Dec 31, 2007	203.20M	-41.66%
Dec 29, 2006	348.30M	177.97%
Dec 30, 2005	125.30M	-36.40%
Dec 31, 2004	197.00M	-11.46%

View and export this data all the way back to 2004. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	574.04B
Johnson & Johnson	416.11B
AbbVie	350.91B
UnitedHealth Group	236.90B
AstraZeneca	232.33B
Novartis AG	230.64B
Abbott Laboratories	228.03B
Novo Nordisk	223.00B

Market Cap Rankings